.png)
Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Today, the FDA is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies including Hims & Hers and other compounding pharmacies as similar alternatives to FDA-approved drugs
Patients will also be charged a monthly provider support fee of $79/month
However, the drugs are costly -- people without insurance face paying more than $1,000 a month to take them
Research Applications Published Research Peer-reviewed studies from PubMed
Healthcare providers evaluate therapeutic progress, injection site tolerance, any side effects or concerns, and overall satisfaction with the therapy experience
Any cloudiness or particles indicate degradation and the vial should not be used
US$ 28.36
US$ 27.29
US$ 22.89
US$ 21.17
US$ 29.53
US$ 24.73
US$ 20.44
US$ 29.38
US$ 21.60
